Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
60.42
+1.67 (2.84%)
At close: Feb 6, 2026
SHA:688336 Market Cap
SHA:688336 has a market cap or net worth of 37.34 billion as of February 6, 2026. Its market cap has increased by 204.11% in one year.
Market Cap
37.34B
Enterprise Value
35.58B
Revenue
1.37B
Ranking
n/a
PE Ratio
43.42
Stock Price
60.42
Market Cap Chart
Since July 22, 2020, SHA:688336's market cap has increased from 33.34B to 37.34B, an increase of 12.02%. That is a compound annual growth rate of 2.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 37.34B | 1.64% |
| Dec 31, 2025 | 36.74B | 178.10% |
| Dec 31, 2024 | 13.21B | -4.84% |
| Dec 29, 2023 | 13.88B | 77.24% |
| Dec 30, 2022 | 7.83B | -31.47% |
| Dec 31, 2021 | 11.43B | -24.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Wantai Biological Pharmacy Enterprise | 52.86B |
| Haisco Pharmaceutical Group | 52.21B |
| Pharmaron Beijing | 51.39B |
| Hebei Changshan Biochemical Pharmaceutical | 46.12B |
| Shanghai Allist Pharmaceuticals | 43.58B |
| Chongqing Zhifei Biological Products | 42.30B |
| Shanghai RAAS Blood Products | 41.81B |
| Asymchem Laboratories (Tianjin) | 35.21B |